Diabetes, Vol 49, Issue 10 1681-1690, Copyright © 2000 by American Diabetes Association

ARTICLES

Glucagon stimulates expression of the inducible cAMP early repressor and suppresses insulin gene expression in pancreatic beta-cells

MA Hussain, PB Daniel and JF Habener
Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Boston 02114, USA.

The hormone glucagon is secreted by the alpha-cells of the endocrine pancreas (islets of Langerhans) during fasting and is essential for the maintenance of blood glucose levels by stimulation of hepatic glucose output. Excessive production and secretion of glucagon by the alpha-cells of the islets is a common accompaniment to diabetes. The resulting hyperglucagonemia stimulates hepatic glucose production, thereby contributing to hyperglycemia of diabetes. The reduced insulin secretion in diabetes and resultant failure to suppress glucagon secretion by intra-islet paracrine mechanisms is believed to cause the hypersecretion of glucagon. Here, we report the discovery of a new mechanism by which glucagon suppresses insulin secretion. We show that glucagon, but not glucagon-like peptide 1 (GLP-1), or pituitary adenylyl cyclase-activating peptide (PACAP) specifically induces the expression of the transcriptional repressor inducible cAMP early repressor (ICER) in pancreatic beta-cells, resulting in a repression of the transcriptional expression of the insulin gene. Remarkably, glucagon, GLP-1, and PACAP all stimulate the formation of cAMP to a comparable extent in rat pancreatic islets, but only glucagon activates the expression of ICER and represses insulin gene transcription in beta-cells. These findings lead us to propose that hyperglucagonemia may additionally aggravate the diabetic phenotype via a suppression of insulin gene expression mediated by the transcriptional repressor ICER.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Wang, R. A. Barke, and S. Roy Transcriptional and Epigenetic Regulation of Interleukin-2 Gene in Activated T Cells by Morphine J. Biol. Chem., March 9, 2007; 282(10): 7164 - 7171. [Abstract] [Full Text] [PDF]

				L. E. Parton, P. J. McMillen, Y. Shen, E. Docherty, E. Sharpe, F. Diraison, C. P. Briscoe, and G. A. Rutter Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E982 - E994. [Abstract] [Full Text] [PDF]

				M. A. Hussain, D. L. Porras, M. H. Rowe, J. R. West, W.-J. Song, W. E. Schreiber, and F. E. Wondisford Increased Pancreatic {beta}-Cell Proliferation Mediated by CREB Binding Protein Gene Activation Mol. Cell. Biol., October 15, 2006; 26(20): 7747 - 7759. [Abstract] [Full Text] [PDF]

				B. N Friedrichsen, N. Neubauer, Y. C Lee, V. K Gram, N. Blume, J. S Petersen, J. H Nielsen, and A. Moldrup Stimulation of pancreatic {beta}-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J. Endocrinol., March 1, 2006; 188(3): 481 - 492. [Abstract] [Full Text] [PDF]

				A. Inada, Y. Hamamoto, Y. Tsuura, J.-i. Miyazaki, S. Toyokuni, Y. Ihara, K. Nagai, Y. Yamada, S. Bonner-Weir, and Y. Seino Overexpression of Inducible Cyclic AMP Early Repressor Inhibits Transactivation of Genes and Cell Proliferation in Pancreatic {beta} Cells Mol. Cell. Biol., April 1, 2004; 24(7): 2831 - 2841. [Abstract] [Full Text] [PDF]

				J. R. Mead, T. R. Hughes, S. A. Irvine, N. N. Singh, and D. P. Ramji Interferon-gamma Stimulates the Expression of the Inducible cAMP Early Repressor in Macrophages through the Activation of Casein Kinase 2. A POTENTIALLY NOVEL PATHWAY FOR INTERFERON-gamma -MEDIATED INHIBITION OF GENE TRANSCRIPTION J. Biol. Chem., May 9, 2003; 278(20): 17741 - 17751. [Abstract] [Full Text] [PDF]

				K. Tenbrock, Y.-T. Juang, M. Tolnay, and G. C. Tsokos The Cyclic Adenosine 5'-Monophosphate Response Element Modulator Suppresses IL-2 Production in Stimulated T Cells by a Chromatin-Dependent Mechanism J. Immunol., March 15, 2003; 170(6): 2971 - 2976. [Abstract] [Full Text] [PDF]

				K. Tenbrock, Y.-T. Juang, M. F. Gourley, M. P. Nambiar, and G. C. Tsokos Antisense Cyclic Adenosine 5'-Monophosphate Response Element Modulator Up-Regulates IL-2 in T Cells from Patients with Systemic Lupus Erythematosus J. Immunol., October 15, 2002; 169(8): 4147 - 4152. [Abstract] [Full Text] [PDF]

				M. Tsutsumi, T. H. Claus, Y. Liang, Y. Li, L. Yang, J. Zhu, F. Dela Cruz, X. Peng, H. Chen, S. L. Yung, et al. A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal: A Potential Therapy for Type 2 Diabetes Diabetes, May 1, 2002; 51(5): 1453 - 1460. [Abstract] [Full Text] [PDF]

				A. K. Busch, D. Cordery, G. S. Denyer, and T. J. Biden Expression Profiling of Palmitate- and Oleate-Regulated Genes Provides Novel Insights Into the Effects of Chronic Lipid Exposure on Pancreatic {beta}-Cell Function Diabetes, April 1, 2002; 51(4): 977 - 987. [Abstract] [Full Text] [PDF]

				G. C. Webb, M. S. Akbar, C. Zhao, H. H. Swift, and D. F. Steiner Glucagon Replacement via Micro-Osmotic Pump Corrects Hypoglycemia and {alpha}-Cell Hyperplasia in Prohormone Convertase 2 Knockout Mice Diabetes, February 1, 2002; 51(2): 398 - 405. [Abstract] [Full Text] [PDF]